(Reuters) - Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in the U.S. at a $150 discount to the cost of the injector pen versions ...
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid Brendan McDermid/Reuters ...
Investing.com - Eli Lilly (NYSE ... at a roughly $150 discount to its injector pen versions. Shares in the group edged higher in early U.S. trading. Lilly said in a statement that patients could ...
Lilly Offers Weight-Loss Drugs in Vials at a Discount to Fight Competition By Patrick Wingrove and Sriparna Roy (Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss ...
In this week’s edition of InnovationRx, we look at Eli Lilly ... On Tuesday, Lilly began selling higher doses of Zepbound in the U.S. at a discount of $150 compared to the injector pen versions ...